Atea Pharmaceuticals Inc (AVIR) Company Profile & Statistics

Atea Pharmaceuticals Inc
AVIR
(Nasdaq - US)
N/A
3.87
+0.17 (+4.59%)
in:usd•As of: May 01, 2024 15:59 UTC -4
Open
3.80
High
3.93
Low
3.78

About Atea Pharmaceuticals Inc

CEO

Jean-Pierre Sommadossi

Headquarters

225 franklin street, suite 2100

boston, ma 02110, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.ateapharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

Atea Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	325.93M
Enterprise Value	182.11M
Enterprise Value/EBITDA (ttm)	-1.02
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.56
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-23.07%
Return on Invested Capital (ttm)	-23.17%
Return on Assets (ttm)	-22.04%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-179.19M
Net Income Avi to Common (ttm)	-135.96M
Diluted EPS (ttm)	-1.64

Share Statistics

Beta (5Y Monthly)	0.16
52-Week Change	19.08%
S&P500 52-Week Change	23.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	84.16M
Dividend Yield	0.00%
Float ⁴	71.96M
% Held by Insiders	14.50%
% Held by Institutions	86.67%

Balance Sheet

Total Cash (mrq)	578.11M
Total Cash Per Share (mrq)	6.87
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	18.24%
Quick Ratio (mrq)	18.24%
Book Value Per Share (mrq)	6.65

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.02
Free Cash Flow (ytd)	-85.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Atea Pharmaceuticals Inc

Trade With A Regulated Broker